Skip to main content

Intuitive Surgical Value Stock - Dividend - Research Selection

Intuitive surgical

ISIN: US46120E6023 , WKN: 888024

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield %
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



Description Data
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

Intuitive designs, manufactures and markets da Vinci Surgical Systems and related instruments and accessories, which taken together, are advanced surgical systems that we consider an advanced generation of surgery. This advanced generation of surgery, which we call da Vinci surgery, combines the benefits of minimally invasive surgery (“MIS”) for patients with the ease of use, precision and dexterity of open surgery. A da Vinci Surgical System consists of a surgeon’s console, a patient-side cart, and a high performance vision system. The da Vinci Surgical System translates a surgeon’s natural hand movements, which are performed on instrument controls at a console, into corresponding micro-movements of instruments positioned inside the patient through small incisions, or ports. The da Vinci Surgical System is designed to provide its operating surgeons with intuitive control, range of motion, fine tissue manipulation capability and Three Dimensional (“3-D”), High-Definition (“HD”) vision while simultaneously allowing surgeons to work through the small ports enabled by MIS procedures.

 

da Vinci Surgery utilizes computational, robotic and imaging technologies to enable improved patient outcomes compared to other surgical and non-surgical therapies. da Vinci Surgery is aimed towards advancing the critical surgical ideals of entering the body less invasively, seeing anatomy more clearly, interacting with tissue more precisely and building surgical skills. The da Vinci Surgical System enables surgeons to avail or improve the benefits of MIS to many patients who would otherwise undergo a more invasive surgery. Surgeons using the da Vinci system operate while seated comfortably at a console viewing a 3-D, HD image of the surgical field. This immersive visualization connects surgeons to the surgical field and their instruments. While seated at the console, the surgeon manipulates instrument controls in a natural manner, similar to the more intuitive open surgery technique. Our technology is designed to provide surgeons with a range of motion in the surgical field analogous to the motions of a human wrist, while filtering out the tremor inherent in a surgeon’s hand. In designing our products, we focus on making our technology easy to use.

 

Source: www.sec.gov

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Assessing Intuitive Surgical (ISRG) Valuation After Recent 12% Year To Date Share Price Decline

2026-02-24
Intuitive Surgical (ISRG) is back in focus after recent trading left the stock with a year to date total return of about negative 12%. This has prompted investors to reassess how its valuation lines up with fundamentals. See our latest analysis for Intuitive Surgical. While the latest share price of US$494.02 leaves Intuitive Surgical with a 30 day share price return of about a 6% decline and a year to date share price return of about a 12% decline, the longer view is different. The company...

The Zacks Analyst Blog Highlights Oracle, Intuitive Surgical, Analog Devices and Moving iMage Technologies

2026-02-24
Oracle, Intuitive Surgical and Analog Devices lead fresh research as cloud growth, robotic momentum and AI tailwinds battle margin and tariff risks.

Zacks Industry Outlook Highlights Intuitive Surgical, Edwards Lifesciences and Electromed

2026-02-24
Intuitive Surgical, Edwards and Electromed tap GenAI tailwinds as AI healthcare spending surges, despite industry under performance.

Intuitive Surgical Inc (NASDAQ:ISRG) Presents a Compelling Mix of Strong Fundamentals and a Bullish Technical Setup

2026-02-24
Intuitive Surgical (ISRG) combines strong fundamentals with a bullish technical setup, offering a potential growth and timing opportunity.

Top Research Reports for Oracle, Intuitive Surgical & Analog Devices

2026-02-23
Oracle faces cloud competition and earnings volatility, yet AI-driven infrastructure growth and strong cash flow aim to power its next phase.

Da Vinci 5 Sparks Optimism Around Intuitive Surgical, Inc. (ISRG)

2026-02-23
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 10 best healthcare equipment stocks to buy according to hedge funds. On January 27, Freedom Capital increased the price target on Intuitive Surgical, Inc. (NASDAQ:ISRG) from $560 to $610, and also upgraded its rating on the stock from Hold to Buy. The upward revision in the target […]

AI robots may outnumber workers in a few decades, ex-Citi executive says

2026-02-23
"You can already buy a humanoid today, which gives you a payback period versus human workers of less than 10 weeks," a former Citi executive told CNBC.

How The Intuitive Surgical (ISRG) Story Is Shifting With Dv5, FDA Clears, And Valuation Jitters

2026-02-23
Intuitive Surgical’s fair value estimate has been updated to US$611.82 per share from US$596.36, a move of about 2.6% that reflects a refined view of the company’s long term setup. Behind this shift, recent analyst research points to a split narrative, with some highlighting the Dv5 rollout, procedure trends, and sector conditions into 2026, while others focus on valuation, sector rotation risk, and policy headlines. In the sections that follow, you will see how these moving pieces fit...

Intuitive Surgical: This Robotic-Surgery Leader Could Keep Compounding for Another Decade

2026-02-22
The company's years of beating the market aren't over yet.

Forget Ozempic: This High‑Flying Device Maker Can Thrive No Matter Which Weight Loss Drug Wins

2026-02-20
Wall Street is overly focused on GLP-1 drugs even as this medical device maker continues to thrive.